Anebulo Pharmaceuticals, Inc. Appoints Nat Calloway as Class II Director

Anebulo Pharmaceuticals, Inc. at its 2022 Annual Meeting of Stockholders held on October 28, 2022, approved the appointment of Nat Calloway to the Board of Directors to hold office until the 2025 Annual Meeting of Stockholders as Class II directors.